| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/31/1994 | EP0612531A1 Therapeutic agent for digestive tract diseases |
| 08/31/1994 | EP0612530A2 Pharmaceutical preparations containing tumor cytotoxic factor |
| 08/31/1994 | EP0612529A2 Therapeutic agent for NIDDM |
| 08/31/1994 | EP0612525A1 Transdermal treatment with mast cell degranulating agents for drug-induced hypersensitivity |
| 08/31/1994 | EP0612522A1 Composition and method for reducing the risk of hypotension |
| 08/31/1994 | EP0612348A1 Recombinant bone morphogenetic protein heterodimers, compositions and methods of use |
| 08/31/1994 | EP0612324A1 Phosphonopeptides with collagenase inhibiting activity |
| 08/31/1994 | EP0612251A1 Stabilised antibodies |
| 08/31/1994 | EP0612249A1 Methods of inhibiting restenosis |
| 08/31/1994 | EP0612216A1 Phospholipid antimicrobial compositions |
| 08/31/1994 | EP0540582B1 Growth hormone crystals and a process for production of these gh-crystals |
| 08/31/1994 | EP0502987B1 Acylated bradykinin antagonists and uses therefor |
| 08/31/1994 | EP0408691B1 Antinephrotoxic perfusion solution |
| 08/31/1994 | EP0374257B1 STABLE INTERFERON $g(b) COMPOSITION |
| 08/31/1994 | EP0259475B1 Recombinant human endothelial cell growth factor |
| 08/31/1994 | EP0228449B1 Fibroblast growth factor |
| 08/31/1994 | CN1091470A Unreductases produced of saccharide preparation and application of same |
| 08/31/1994 | CN1091469A PTP 1D, a novel protein tyrosine phosphatase |
| 08/31/1994 | CN1091432A Peptides capable of inhibiting the activity of HIV protease, their preparation and their therapeutic use |
| 08/31/1994 | CN1091316A Method and composition for the treatment |
| 08/31/1994 | CN1091315A Fibrin sealant compositions and methods for utilizing same |
| 08/31/1994 | CN1091314A Pharmaceutical compositions containing a calcitonin |
| 08/30/1994 | US5342977 Aminosulfonic acid derivatives and processes for their preparation |
| 08/30/1994 | US5342940 Reacting with cyanuric chloride; modified proteins |
| 08/30/1994 | US5342930 Genetic engineering |
| 08/30/1994 | US5342924 Extracellular segments of human ε immunoglobulin anchoring peptides and antibodies specific therefor |
| 08/30/1994 | US5342922 Inhibitors of retroviral protease |
| 08/30/1994 | US5342831 Wound healing, bed sores |
| 08/30/1994 | US5342830 Antithrombosis agents |
| 08/30/1994 | US5342774 Nucleotide sequence encoding the tumor rejection antigen precursor, MAGE-1 |
| 08/30/1994 | US5342764 Recombinant expression system for human anti-inflammatory phospholipase inhibitor protein |
| 08/30/1994 | US5342761 Oncofetal gene, gene product and uses therefor |
| 08/30/1994 | US5342757 Monoclonal antibodies which specifically binds to endosialin, a 165 Kd glycoprotein found on tumor vascular endothelium, and uses thereof |
| 08/30/1994 | US5342752 Method of inactivation of viral blood contaminants using acridine deriatives |
| 08/30/1994 | US5342625 Hydrophilic phase of di-or partial ether and propylene glycol, lipophilic phase adn surfactant; immunmosuppressive, antiinflammatory, antiparasitic agent |
| 08/30/1994 | US5342616 Method of administering tissue plasminogen activator |
| 08/30/1994 | US5342615 Method for treating arthritis or inflammation with Il-1α or derivatives thereof |
| 08/30/1994 | US5342614 Administering interleukin-1-beta |
| 08/30/1994 | US5342613 Administering tumor necrosis factor |
| 08/27/1994 | CA2116489A1 Pacap receptor protein, method for preparing said protein and use thereof |
| 08/26/1994 | CA2115404A1 Tumor suppressor gene merlin and uses thereof |
| 08/26/1994 | CA2114968A1 Transdermal treatment with mast cell degranulating agents for drug-induced hypersensitivity |
| 08/25/1994 | DE4337197C1 Process for the selective preparation of hybridoma cell lines which produce monoclonal antibodies with high cytotoxicity against human CD16 antigen, and the preparation of bispecific monoclonal antibodies using such monoclonal antibodies and the CD30-HRS-3 antibody for therapy of human tumours |
| 08/25/1994 | DE4305063A1 Receptor derivatives |
| 08/25/1994 | CA2116181A1 Peptide derivatives of boronic acid, a process for their preparation and pharmaceutical compositions containing them |
| 08/25/1994 | CA2115377A1 Therapeutic agent for digestive tract diseases |
| 08/24/1994 | EP0611776A2 New pseudopeptides with antiviral activity |
| 08/24/1994 | EP0611775A2 Human cancer inhibitory pentapeptide amides |
| 08/24/1994 | EP0611756A2 Alcohol or aldehyde derivatives as cathepsin L inhibitor and bone resorption inhibitor |
| 08/24/1994 | EP0611573A2 Bioactive conjugates of cellulose with amino compounds |
| 08/24/1994 | EP0611572A2 Process to prepare a cetrorelix lyophilised composition |
| 08/24/1994 | EP0611571A1 Teicoplanin containing topical compositions with delayed release of the active agent |
| 08/24/1994 | EP0611394A1 Cellular nucleic acid binding protein and uses thereof in regulating gene expression and in the treatment of aids |
| 08/24/1994 | EP0611376A1 Production and use of multimeric hemoglobins |
| 08/24/1994 | EP0611375A1 Peptides inhibiting il-1 beta release |
| 08/24/1994 | EP0611306A1 Hemoglobins as drug delivery agents |
| 08/24/1994 | EP0611305A1 Stabilization of human interferon |
| 08/24/1994 | EP0611302A1 Methods and compositions for treating allergic reactions |
| 08/24/1994 | EP0560809B1 Agent for reducing the growth of, or removing, human body hair |
| 08/24/1994 | EP0556344A4 New insulin-like growth factor binding protein (igfbp-6) |
| 08/24/1994 | EP0504191B1 Method and composition for the treatment of mammalian hiv infection |
| 08/24/1994 | EP0478631B1 Targetting agents |
| 08/24/1994 | EP0471761B1 Use of a GnRHanalog for the manufacture of a medicament for the treatment of motility disorders |
| 08/24/1994 | EP0423214B1 Purification and administration of dna repair enzymes |
| 08/24/1994 | EP0359745B1 Growth factor receptor |
| 08/24/1994 | EP0358708B1 Blood substitutes |
| 08/24/1994 | EP0314755B1 Use of derivatives of GHL-Cu for the manufacture of a medicament for stimulating hair growth |
| 08/24/1994 | CN1091139A PTP-D subfamily of protein tyrosine phosphatases |
| 08/24/1994 | CN1025738C Method for preparation of novel peptide-aldehyde compound and composition of same |
| 08/24/1994 | CA2090171A1 Opioid receptor antagonists, their synthesis and use as analgesic and immunosuppressive compounds |
| 08/23/1994 | WO1994019371A1 Novel peptide having elastase inhibitor activity and process for producing the same |
| 08/23/1994 | US5340923 Methods for making and purifying antivenoms |
| 08/23/1994 | US5340922 Polypeptide |
| 08/23/1994 | US5340920 Physiologically active porcine peptide (CNP-53) |
| 08/23/1994 | US5340828 Anticarcinogenic agents |
| 08/23/1994 | US5340825 Pro drugs for CCK antagonists |
| 08/23/1994 | US5340802 Central nervous system disorders |
| 08/23/1994 | US5340801 Compounds having cholecystokinin and gastrin antagonistic properties |
| 08/23/1994 | US5340800 Peptide medicaments for the treatment of disease |
| 08/23/1994 | US5340798 Fibrinogen receptor antagonists |
| 08/23/1994 | US5340739 Hematopoietic cell specific transcriptional regulatory elements of serglycin and uses thereof |
| 08/23/1994 | US5340736 ATP-dependent protease and use of inhibitors for same in the treatment of cachexia and muscle wasting |
| 08/23/1994 | US5340732 Antiviral protein |
| 08/23/1994 | US5340727 GPIbα fragments and recombinant DNA expression vectors |
| 08/23/1994 | US5340726 Protein for inhibiting collagen-stimulated platelet aggregation |
| 08/23/1994 | US5340586 Slow release formulations of estrogens and androgens |
| 08/23/1994 | US5340585 Method and formulations for use in treating benign gynecological disorders |
| 08/23/1994 | US5340584 Gonadotropin hormone releasing hormone, an estrogenic composition and a progestogen |
| 08/23/1994 | US5340574 Stabilized non-glycosylated recombinant human IL2 in reduced form compositions |
| 08/23/1994 | US5340573 Using macrophage colony stimulating factor |
| 08/23/1994 | US5340565 Tumor or cancer cell killing therapy and agents useful therefor |
| 08/23/1994 | CA2115972A1 Cyclopeptide derivatives of angiopeptin, process for the preparation thereof and pharmaceutical compositions containing same |
| 08/23/1994 | CA1331672C Peptidic derivatives having a polycyclic nitrogenous structure and process for the preparation thereof |
| 08/23/1994 | CA1331615C Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids |
| 08/23/1994 | CA1331614C Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline- 3-carboxylic acids |
| 08/23/1994 | CA1331536C Enteral diet product and agent for production thereof |
| 08/21/1994 | CA2115966A1 Chrysospermins, active peptides from apiocrea chrysosperma having a pharmacological effect, a process for their preparation and the use thereof |
| 08/20/1994 | CA2115913A1 Alcohol or aldehyde derivatives and their use |
| 08/19/1994 | CA2115815A1 Pharmaceutical compositions |
| 08/18/1994 | WO1994018562A1 Human carcinoma antigen (hca), hca antibodies, hca immunoassays, methods of imaging and therapy |